Enter your first name:

Enter your last name:

Enter your user name: This is your forum name Enter your email: This is your login ID Verify your email: Choose your password: Confirm your password: Where did you hear about us?: Validation Code:

Overcoming Multiple Sclerosis Overcoming Multiple Sclerosis

Normal text size Large text size Add to Favourites > High contrast mode Standard site view

Professor Jelinek - Guest speaker at Australasian College of Phlebology 14th Annual Scientific Meeting

30 Mar 2011 - 3 Apr 2011

Sofitel, Melbourne, Australia

Professor Jelinek - Guest speaker at Australasian College of Phlebology 14th Annual Scientific Meeting

The all day symposium will be on Friday 1st April 2011, and the Professor will be speaking at 1pm on the topic of:

Lifestyle-modification management of multiple sclerosis may operate through beneficial vascular effects.

The Professor will also take part in a panel discussion on CCSVI, along with Professor Zamboni and others.

Please see following link for information on the other guest speakers invited to attend:
http://www.cdesign.com.au/ACP2011/speakers.html
You can also download the flyer brochure here.

Back to Events listing

Latest Events
Gawler Foundation Retreat - October 2012
22 Oct 2012 - 26 Oct 2012
Gawler Foundation Retreat - August 2012
20 Aug 2012 - 24 Aug 2012
OMS to be featured at MS Life in Manchester 14-15 April 2012
14 Apr 2012 - 15 Apr 2012
Additional Gawler Foundation Retreat - March 2012
26 Mar 2012 - 30 Mar 2012
Gawler Foundation Retreat - March 2012
12 Mar 2012 - 16 Mar 2012

Please note... To remain completely unbiased and independent OMS is an independent website that receives no funding from the pharmaceutical industry, device manufacturers, or other companies and is not affiliated with any 3rd party groups or organisations.

| | Sitemap

Professor Jelinek - Guest speaker at Australasian College of Phlebology 14th Annual Scientific Meeting

30 Mar 2011 - 3 Apr 2011

Sofitel, Melbourne, Australia

Latest Events

News and Events

Please note... To remain completely unbiased and independent OMS is an independent website that receives no funding from the pharmaceutical industry, device manufacturers, or other companies and is not affiliated with any 3rd party groups or organisations.